HomeToday’s HighlightsThe Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. The Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. Today’s Highlights April 8, 2019 The Amgen/Novartis Story In May 2018 Amgen (AMGN) & Novartis (This content is for paid subscribers. Please click here to subscribe or here to log in. Today’s Highlights Alder BioPharmaceuticals (ALDR), Amgen (AMGN), Novartis (NVS) April 8, 2019 Tweet Pin It Other Articles Vertex Pharmaceuticals Announces Advancements of Its Product Suzetrigine for Acute and Neuropathic Pain April 18, 2024 0 Madrigal Pharmaceuticals Announces U.S. Availability of its Newly Approved Product Rezdiffra April 9, 2024 0 Johnson & Johnson to Acquire Shockwave Medical April 5, 2024 0 BioStem Technologies is Releasing its Fourth Quarter 2023 Financial Results Now April 1, 2024 0